Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1

• Автори: Fangbo Zhang (Автор), Feifei Guo (Автор), Yang Liu (Автор), Yi Zhang (Автор), Defeng Li (Автор), Hongjun Yang (Автор)
• Формат: Книга
• Опубліковано: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Background: Chronic obstructive pulmonary disease (COPD) is the most common respiratory disease with high morbidity and mortality. Shema oral liquid (Shema) is a traditional Chinese medicine (TCM) approved for the treatment of respiratory diseases. Clinical applications have shown that Shema has ant...